Initial Evaluation of Cyfra 21-1 Diagnostic Performances as a Urinary Marker in Bladder Transitional Cell Carcinoma
- 1 August 1997
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 158 (2), 338-341
- https://doi.org/10.1016/s0022-5347(01)64473-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Clinical Evaluation of Cell Deoxyribonucleic Acid Content Measured by Flow Cytometry in Bladder CancerJournal of Urology, 1996
- Initial Evaluation of the Bladder Tumor Antigen Test in Superficial Bladder CancerJournal of Urology, 1996
- Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancerBritish Journal of Urology, 1996
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancerEuropean Respiratory Journal, 1995
- Low grade transitional cell carcinoma of the bladder. Cytologic Diagnosis by Key Features as Identified by Logistic Regression AnalysisCancer, 1994
- Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1British Journal of Cancer, 1994
- CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluationEuropean Journal Of Cancer, 1994
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsCell, 1982
- The efficacy of urinary cytology in the detection of urothelial tumoursUrological Research, 1978